| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie |
NCT01376076: Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia |
|
|
| Completed | 1 | 129 | US | Cariprazine, Risperidone/Moxifloxacin | Forest Laboratories | Schizophrenia | 02/12 | 02/12 | | |
NCT02165098: Cariprazine: Comparison of Slow- and Immediate-release Forms |
|
|
| Completed | 1 | 160 | Europe | Cariprazine prolonged release tablet A, Cariprazine prolonged release tablet B, Cariprazine capsule, Cariprazine PR tablet A, Cariprazine PR tablet B | Gedeon Richter Plc. | Pharmacokinetic Profile | 02/16 | 02/16 | | |
2016-002327-29: A study to evaluate pharmacokinetics, safety and tolerability of Cariprazine in adolescent subjects with schizophrenia compared to adults |
|
|
| Completed | 1 | 83 | Europe | Cariprazine, RGH-188, Capsule, hard | Gedeon Richter Plc., Gedeon Richter Plc. | Schizophrenia, Schizoaffective- and Schizophreniform Disorders, Schizophrenia, Schizoaffective- and Schizophreniform Disorders, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
| Completed | 1 | 24 | US | Cariprazine | AbbVie | Autism Spectrum Disorder | 12/21 | 12/21 | | |
| Completed | 1 | 29 | RoW | Test Product (Vocarzine), Reference (R) Reagila ® | Aya Mohammed Abdel Magid Abdel Hamid, Advanced Research Center (ARC), Atco Pharma for Pharmaceutical Industries, Egypt | Bioequivalence Study in Healthy Subjects | 01/25 | 01/25 | | |
